Advances in epidemiology and diagnosis of inflammatory bowel diseases

Current Gastroenterology Reports

Volumn 10, Issue 6, 2008, Pages 576-584

  Ali, Sobia ^b   Tamboli, Cyrus P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CALGRANULIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; LACTOFERRIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ABDOMINAL RADIOGRAPHY; ANTIBODY DETECTION; APPENDECTOMY; CAMPYLOBACTER; CAPSULE ENDOSCOPY; CHROMOENDOSCOPY; CIGARETTE SMOKING; CLOSTRIDIUM DIFFICILE; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL MICROSCOPY; CROHN DISEASE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DOUBLE BALLOON ENTEROSCOPY; ECHOGRAPHY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; FISTULOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INCIDENCE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERSONAL HYGIENE; PREVALENCE; PROCTOCOLECTOMY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALMONELLA; SEROLOGY; SHIGELLA; THEORY; ULCERATIVE COLITIS; UNITED STATES; VACCINATION;

CLOSTRIDIUM INFECTIONS; ENDOSCOPY, GASTROINTESTINAL; HUMANS; HYGIENE; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 60749117793     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0105-9     Document Type: Review

References (50)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al.: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007, 5:1424-1429.
2. Herrinton LJ, Liu L, Lafata JE, et al.: Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007, 13:451-461.
3. Loftus CG, Loftus EV Jr, Harmsen WS, et al.: Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007, 13:254-261.
4. Bernstein CN, Wajda A, Svenson LW, et al.: The epidemiology of inflammatory bowel disease in Canada: A population-based study. Am J Gastroenterol 2006, 101:1559-1568.
5. Gunesh S, Thomas GA, Williams GT, et al.: The incidence of Crohn's disease in Cardiff over the last 75 years: An update for 1996-2005. Aliment Pharmacol Ther 2008, 27:211-219.
6. Gearry RB, Richardson A, Frampton CM, et al.: High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study. Inflamm Bowel Dis 2006, 12:936-943.
7. Sood A, Midha V, Sood N, et al.: Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003, 52:1587-1590.
8. Yang SK, Yun S, Kim JH, et al.: Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study. Inflamm Bowel Dis 2008, 14:542-549.
9. Edwards CN, Griffith SG, Hennis AJ, Hambleton IR: Inflammatory bowel disease: Incidence, prevalence, and disease characteristics in Barbados, West Indies. Inflamm Bowel Dis 2008, 14:1419-1424.
10. Abdul-Baki H, ElHajj I, El-Zahabi LM, et al.: Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis 2007, 13:475-480.
11. Nerich V, Monnet E, Etienne A, et al.: Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data. Inflamm Bowel Dis 2006, 12:218-226.
12. Tsironi E, Feakins RM, Probert CS, et al.: Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004, 99:1749-1755.
13. Pinsk V, Lemberg DA, Grewal K, et al.: Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007, 102:1077-1083.
14. Carr I, Mayberry JF: The effects of migratAon on ulcerative colitis: a three-year prospective study among Europeans and first-and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999, 94:2918-2922.
15. Bernstein CN, Rawsthorne P, Blanchard JF: Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:759-762.
16. Kaplan GG, Pedersen BV, Andersson RE, et al.: The risk of developing Crohn's disease after an appendectomy: A population-based cohort study in Sweden and Denmark. Gut 2007, 56:1387-1392.
17. Hallas J, Gaist D, Sorensen HT: Does appendectomy reduce the risk of ulcerative colitis? Inflamm Bowel Dis 2004, 15:173-178.
18. Lakatos PL, Szamosi T, Lakatos L: Smoking in inflammatory bowel diseases: Good, bad or ugly? World J Gastroenterol 2007, 13:6134-6139.
19. Garcia Rodriguez LA, Ruigomez A, Panes J: Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006, 130:1588-1594.
20. Halfvarson J, Jess T, Magnuson A, et al.: Environmental factors in inflammatory bowel disease: A co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006, 12:925-933.
21. Wehkamp J, Salzman NH, Porter E, et al.: Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005, 102:18129-18134.
22. Hugot JP: CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci 2006, 1072:9-18.
23. Tremaine WJ: Inflammatory bowel disease and Clostridium difficile-associated diarrhea: A growing problem. Clin Gastroenterol Hepatol 2007, 5:310-311.
24. McDonald LC, Killgore GE, Thompson A, et al.: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
25. Issa M, Vijayapal A, Graham MB, et al.: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345-351.
26. Jones PH, Farver TB, Beaman B, et al.: Crohn's disease in people exposed to clinical cases of bovine paratuberculosis. Epidemiol Infect 2006, 134:49-56.
27. Feller M, Huwiler K, Stephan R, et al.: Mycobacterium avium subspecies paratuberculosis and Crohn's disease: A systematic review and meta-analysis. Lancet Infect Dis 2007, 7:607-613.
28. Abubakar I, Myhill D, Aliyu SH, Hunter PR: Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: A systematic review and meta-analysis. Inflamm Bowel Dis 2008, 14:401-410.
29. Cousins DV, Whittington R, Marsh I, et al.: Mycobacteria distinct from Mycobacterium avium subsp. paratuberculosis isolated from the faeces of ruminants possess IS 900-like sequences detectable IS 900 polymerase chain reaction: Implications for diagnosis. Mol Cell Probes 1999, 13:431-442.
30. Braun-Fahrlander C, Riedler J, Herz U, et al.: Environmental exposure to endotoxin and its relation to asthma in schoolage children. N Engl J Med 2002, 347:869-877.
31. Weinstock JV, Summers RW, Elliott DE, et al.: The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med 2002, 139:334-338.
32. Amre DK, Lambrette P, Law L, et al.: Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: A case-control study. Am J Gastroenterol 2006, 101:1005-1011.
33. Bernstein CN, Rawsthorne P, Cheang M, et al.: A populationbased case control study of potential risk factors for IBD. Am J Gastroenterol 2006, 101:993-1002.
34. Lashner BA, Loftus EV Jr: True or false? The hygiene hypothesis for Crohn's disease. Am J Gastroenterol 2006, 101:1003-1004.
35. Radon K, Windstetter D, Poluda AL, et al.: Contact with farm animals in early life and juvenile inflammatory bowel disease: A case-control study. Pediatrics 2007, 120:354-361.
36. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M: IBD serological panels: Facts and perspectives. Inflamm Bowel Dis 2007, 13:1561-1566.
37. Ashorn S, Raukola H, Valineva T, et al.: Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol 2008, 28:486-494.
38. Toumi D, Mankai A, Belhadj R, et al.: Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol 2007, 42:821-826.
39. Makharia GK, Sachdev V, Gupta R, et al.: Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci 2007, 52:33-39.
40. Mallant-Hent R, Mary B, von Blomberg E, et al.: Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 2006, 18:75-78.
41. Reese GE, Constantinides VA, Simillis C, et al.: Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2006, 101:2410-2422.
42. Dotan I, Fishman S, Dgani Y, et al.: Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006, 131:366-378.
43. Fleshner P, Ippoliti A, Dubinsky M, et al.: Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:561-568.
44. Dendrinos KG, Becker JM, Stucchi AF, et al.: Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouchanal anastomosis. J Gastrointest Surg 2006, 10:1060-1064.
45. Schoepfer AM, Trummler M, Seeholzer P, et al.: Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008, 14:32-39.
46. Langhorst J, Elsenbruch S, Koelzer J, et al.: Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008, 103:162-169.
47. Sipponen T, Savilahti E, Kolho KL, et al.: Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's Disease Activity Index and endoscopic findings. Inflamm Bowel Dis 2008, 14:40-46.
48. Triester SL, Leighton JA, Leontiadis GI, et al.: A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol 2006, 101:954-964.
49. Biancone L, Calabrese E, Petruzziello C, et al.: Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 2007, 13:1256-1265.
50. Lashner BA: Sensitivity-specificity trade-off for capsule endoscopy in IBD: Is it worth it? Am J Gastroenterol 2006, 101:965-966.